SAFEstart Feeding Intolerance Study Phase II

NCT00331201 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Feeding Intolerance
Abdominal Distention
Gastric Residual
Emesis and Diarrhea
Blood in Stool

Interventions

DRUG: SAFEstart

Sponsor

Intermountain Health Care, Inc.